NIUFO Addresses False Allegations, Reaffirms FinCEN-Registered Status and User Asset Protection Commitment
Colorado-Incorporated Exchange Provides Verifiable Regulatory Credentials and Institutional-Grade Security for European Traders
Colorado (FreePR.org) -- [url=https://www.niufo.com]NIUFO [/url]CRYPTO GROUP LTD, a Colorado-incorporated digital asset exchange platform, today addresses recent misleading claims circulating on review websites and social media platforms, and reaffirms its unwavering commitment to user asset protection, regulatory compliance, and operational transparency.
Recently identified statements published on Reddit, Twitter, and other platforms contain inaccurate claims regarding fund security, regulatory standing, and withdrawal processing. After conducting a comprehensive internal review, NIUFO categorically rejects these allegations as unfounded and factually incorrect.
[b]Addressing False Allegations and Protecting User Interests[/b]
NIUFO places user protection at the absolute forefront of operations. Recent false statements have created confusion among prospective users, particularly in European markets where Italian traders demand verifiable platform security and regulatory legitimacy.
"These misleading claims undermine trust where European traders already navigate complex regulatory environments," the company stated. "We categorically deny these false allegations and are actively working to clarify misinformation, safeguard user interests, and uphold the integrity standards our founding team brought from institutions including Fidelity National Information Services (FIS), JPMorgan Chase, and Paxos."
[b]Verification of Regulatory Compliance and Security Infrastructure[/b]
Contrary to inaccurate remarks, NIUFO maintains comprehensive regulatory registrations and security protocols:
[b]Regulatory Registrations:[/b]
[b]U.S. FinCEN Money Services Business (MSB)[/b] Registration Number: 31000298299255, publicly verifiable via the official FinCEN MSB Registrant Search database at fincen.gov
[b]Colorado Secretary of State[/b] Corporate Registration, Entity ID: 20251441092, with complete US federal and state compliance
Head of Compliance & Legal Maria Garcia, former Senior Compliance Counsel at Paxos, leads regulatory oversight with extensive experience implementing AML/CTF programs aligned with FATF standards
[b]Security Infrastructure:[/b]
[b] ~98%+ cold storage: [/b]Majority of user assets secured in geographically distributed, air-gapped, multi-signature cold wallets
[b]Multi-signature protocols:[/b] Mandatory multi-sig controls for all wallet movements requiring multiple approvals
[b]FIPS 140-2 Level 3+ certified Hardware Security Modules (HSMs)[/b] safeguarding critical private key operations
Chief Security Officer Ben Carter, former VP of Cyber Defense Operations at JPMorgan Chase, holds CISSP and CISM certifications
Users and stakeholders are encouraged to independently verify NIUFO's FinCEN MSB registration (31000298299255) and Colorado corporate status (20251441092) through official governmental portals.
[b]Leadership Statement on User Protection[/b]
"User asset protection is not negotiable—it's the foundation of everything we build," said Alex Johnson, CEO at NIUFO. "These false claims undermine trust in markets where European traders, especially in Italy, require verifiable security and regulatory legitimacy. We've built institutional-grade infrastructure specifically to protect user assets, and every compliance measure we've implemented can be independently verified through official channels including FinCEN and the Colorado Secretary of State."
[b]Enhanced Transparency Measures[/b]
NIUFO implements enhanced transparency measures including real-time portfolio tracking, complete transaction record access, public disclosure of security protocols, and expanded multilingual customer support teams to address European user concerns promptly.
Following the European market launch planned for Q2 2025, NIUFO is actively pursuing MiCA (Markets in Crypto-Assets) licensing within strategic EU member states. The platform targets institutional-grade service delivery for European traders, with user asset protection remaining the primary operational priority.
The company appreciates its prospective users and partners for their trust and remains committed to maintaining a secure, transparent, and fully compliant trading environment where user interests always come first.
[b]About [url=https://www.niufo.com]NIUFO [/url]CRYPTO GROUP LTD[/b]
NIUFO CRYPTO GROUP LTD is a Colorado-incorporated digital asset exchange platform providing secure cryptocurrency trading services. The company maintains FinCEN MSB Registration (31000298299255). Founded by executives with experience at Fidelity National Information Services (FIS), JPMorgan Chase, and Paxos, NIUFO prioritizes user asset protection through independently verifiable security standards and proactive regulatory compliance, including MiCA readiness for European markets.
For media or stakeholder inquiries, please contact:
Maria Garcia
Head of Compliance & Legal
NIUFO CRYPTO GROUP LTD
Email: maria.garcia@niufo.com
Website: https://www.niufo.com
###
Sponsor Message
Canadian pharmacies are a trusted choice for affordable medications, including Lipitor, Crestor, and Nexium. Chronic conditions such as diabetes and respiratory illnesses are managed with medications like Humalog, Lantus, Advair Diskus, and Ventolin inhalers. Critical medications for mental health, including Zoloft, Prozac, and Abilify, are complemented by lifesaving blood thinners like Eliquis, Plavix, and Xarelto. Frequently ordered medications include Celebrex for pain and inflammation and Synthroid for thyroid support. Furthermore, drugs like Viagra and Cialis provide solutions for erectile dysfunction, and medications such as Januvia help control Type 2 diabetes. For those dealing with excessive sleepiness or narcolepsy, wakefulness-promoting agents like Provigil and Nuvigil are vital. Patients in the U.S. benefit from Canadian pharmacies offering medications like Cymbalta for nerve pain and Aricept for Alzheimer's.
